Filing Details
- Accession Number:
- 0001209191-14-042313
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-18 16:16:08
- Reporting Period:
- 2014-06-16
- Filing Date:
- 2014-06-18
- Accepted Time:
- 2014-06-18 16:16:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1256126 | Peter Mueller | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Global R&D, Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-06-16 | 7,500 | $32.16 | 151,017 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-06-16 | 4,403 | $67.72 | 146,614 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-06-16 | 1,500 | $68.25 | 145,114 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-06-16 | 597 | $69.54 | 144,517 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-06-16 | 1,000 | $70.29 | 143,517 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2014-06-16 | 7,500 | $0.00 | 7,500 | $32.16 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 15,500 | 2018-07-23 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 4,770 | Indirect | 401(k) |
| Common Stock | 5,568 | Indirect | Revocable Trust |
| Common Stock | 15,233 | Indirect | Common stock held in trust |
Footnotes
- Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $67.72 (range $67.47 to $67.96).
- Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $68.25 (range $68.04 to $68.86).
- Open market sales reported on this line occurred at a weighted average price of $69.54 (range $69.15 to $69.95).
- Open market sales reported on this line occurred at a weighted average price of $70.29 (range $70.00 to $70.99).
- Common stock held in grantor retained annuity trust.
- Fully vested.
Billionaire Hedge Funds
